Search Results 111-120 of 18324 for progesterone

  1. Neurosurgery - Clinical trials

    ... progesterone receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable ...

  2. A Study to Assess Kidney Function Markers in Transgender Individuals Receiving Gender-affirming Hormone Therapy - Mayo Clinic

    Participation eligibility · Individuals < 18 years of age. · Previous use of cross sex hormone therapy: Estrogen;; Testosterone;; Progesterone;; Spironolactone; ...

  3. Neurosurgery - Clinical trials

    ... progesterone receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable ...

  4. A Blood Collection Protocol to Study the Immune Responses of Cancer Patients with Malignancies - Mayo Clinic

    ... progesterone receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable ...

  5. A Study to Evaluate the Effect of Olorinab on Gastrointestinal Transit in Patients with Irritable Bowel Syndrome - Mayo Clinic

    ... progesterone oral contraceptives (“the pill”), estrogen and progesterone transdermal patch, vaginal ring, or progesterone; injection;; Complete sexual ...

  6. Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer - Mayo Clinic

    The primary tumor must have been estrogen receptor (ER)-positive and/or progesterone receptor (PgR)-positive. (Patients who had a tumor that was considered ...

  7. Nicole P. Sandhu, M.D., Ph.D. - Doctors and Medical Staff - Mayo Clinic

    PhD - Molecular Biology: Isolated the gene for oviduct progesterone receptor binding factor from chicken and studied the regulatory elements of the gene in ...

  8. Publications - Zaraq Khan, M.D. - Mayo Clinic

    Progesterone support for frozen embryo transfer: intramuscular versus vaginal suppository demonstrates no difference in a cohort. J Reprod Med. 2015 Mar-Apr ...

  9. Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 - Mayo Clinic

    MP2, these patients are not eligible. - The tumor must be ER and/or PgR-positive (progesterone receptor) by current. ASCO/CAP guidelines based on local ...

  10. Neurosurgery - Clinical trials

    ... progesterone receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable ...